EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

Analysing key trends in medical affairs in 2025

Dive into the latest insights from EMJ GOLD’s contributors to uncover what HCPs really want from medical affairs in 2025.

Pfizer’s Richard Maughan on the future of access in the UK

Richard Maughan, Senior Director and Head of UK Policy and Public Affairs, Pfizer, explores how the UK is shaping access to medicine.

BMS' Anita Gandhi on a decade of change in hematology

This National Blood Week, the team sit down with Anita Gandhi, BMS, to explore the last decade in hematology and what lies ahead.
Yacin Marzouki

Yacin Marzouki on disrupting the traditional omnichannel model

Omnichannel engagement expert Yacin Marzouki joins the show to share his strategies on how to make omnichannel work for both pharmaceutical companies and healthcare professionals. 

GSK’s Dheepa Chari on the evolving sphere of scientific communication

Dheepa Chari joins EMJ GOLD to discuss her career path, AI in pharma and the future of scientific communication.
Charl van Zyl, Dr Dennise Broderick, Christoph von Der Goltz and Rebecca Vermeulen

Season 9 highlights: GOLD Medal Moments

Look back on Season 9’s GOLD Medal Moments with the team before Season 10 begins.
Dennise Broderick Galen Pharma

Galen’s Dr Dennise Broderick on why kindness isn't a weakness in business

Dr Dennise Broderick, President and Managing Director, Galen Pharma joins the GOLD podcast to discuss her life-long ambition to be a leader and how she approaches hard decisions in business. 
Boehringer Ingelheim's Christoph von der Goltz

Boehringer’s Christoph von der Goltz on setbacks and success in R&D

How can pharma navigate setbacks in drug development to deliver breakthroughs in R&D? Find out from Christoph von der Goltz, Boehringer.
We’ve noticed you’re accessing
from North/South America.